76 related articles for article (PubMed ID: 26122520)
1. Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates.
Huang RY; Deyanova EG; Passmore D; Rangan V; Deshpande S; Tymiak AA; Chen G
J Am Soc Mass Spectrom; 2015 Oct; 26(10):1791-4. PubMed ID: 26122520
[TBL] [Abstract][Full Text] [Related]
2. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates.
Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124167. PubMed ID: 38823148
[TBL] [Abstract][Full Text] [Related]
3. Intact quantitation of cysteine-conjugated antibody-drug conjugates using native mass spectrometry.
Li Y; Wang Y; Shenoy VM; Niu S; Jenkins GJ; Sarvaiya H
Rapid Commun Mass Spectrom; 2024 Aug; 38(15):e9774. PubMed ID: 38812280
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Multi-attribute Analysis of Antibody-Drug Conjugates Enabled by Trapped Ion Mobility Spectrometry and Top-Down Mass Spectrometry.
Larson EJ; Roberts DS; Melby JA; Buck KM; Zhu Y; Zhou S; Han L; Zhang Q; Ge Y
Anal Chem; 2021 Jul; 93(29):10013-10021. PubMed ID: 34258999
[TBL] [Abstract][Full Text] [Related]
5. Automated high-throughput buffer exchange platform enhances rapid flow analysis of antibody drug conjugates by high resolution mass spectrometry.
Yang Y; Rao R; Valliere-Douglass J; Tremintin G
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Mar; 1235():124007. PubMed ID: 38387340
[TBL] [Abstract][Full Text] [Related]
6. Impact of drug-linker on method selection for analytical characterization and purification of antibody-drug conjugates.
Santora LC; Hobson AD; Wang L; Wu KX
Anal Methods; 2024 Jun; 16(22):3492-3503. PubMed ID: 38770747
[TBL] [Abstract][Full Text] [Related]
7. Drug deconjugation-assisted peptide mapping by LC-MS/MS to identify conjugation sites and quantify site occupancy for antibody-drug conjugates.
Wang T; Huang ZA; Zhou M; Wang R; Li Y; Guo L; Cao X; Huang J
J Pharm Biomed Anal; 2024 Jun; 243():116098. PubMed ID: 38493753
[TBL] [Abstract][Full Text] [Related]
8. A simple and highly sensitive LC-MS workflow for characterization and quantification of ADC cleavable payloads.
Mak SY; Chen S; Fong WJ; Choo A; Ho YS
Sci Rep; 2024 May; 14(1):11018. PubMed ID: 38744902
[TBL] [Abstract][Full Text] [Related]
9. Antibody Polymer Conjugates (APCs) for Active Targeted Therapeutic Delivery.
Kanjilal P; Singh K; Das R; Matte J; Thayumanavan S
Biomacromolecules; 2023 Aug; 24(8):3638-3646. PubMed ID: 37478281
[TBL] [Abstract][Full Text] [Related]
10. Organic-Solvent-Free "Lego-Like" Modular Preparation of Fab-Nondestructive Antibody-Drug Conjugates with Ultrahigh Drug-to-Antibody Ratio.
Liu Z; Zhang H; Sun J; Zheng M; Cui L; Zhang Y; Cheng J; Tang Z; Chen X
Adv Mater; 2023 Nov; 35(46):e2300377. PubMed ID: 37532247
[TBL] [Abstract][Full Text] [Related]
11. Hybrid liquid chromatography high resolution and accuracy mass spectrometry approach for quantification of antibody-drug conjugates at the intact protein level in biological samples.
Barbero LM; Ianni AD; Molinaro F; Cowan KJ; Sirtori FR
Eur J Pharm Sci; 2023 Sep; 188():106502. PubMed ID: 37336420
[TBL] [Abstract][Full Text] [Related]
12. The Evolution of Antibody-Drug Conjugates: Toward Accurate DAR and Multi-specificity.
Dong W; Wang W; Cao C
ChemMedChem; 2024 May; ():e202400109. PubMed ID: 38758596
[TBL] [Abstract][Full Text] [Related]
13. Liquid-phase separations coupled with ion mobility-mass spectrometry for next-generation biopharmaceutical analysis.
Makey DM; Ruotolo BT
Expert Rev Proteomics; 2024 Jun; ():. PubMed ID: 38934922
[TBL] [Abstract][Full Text] [Related]
14. Intact Protein Mass Spectrometry for Therapeutic Protein Quantitation, Pharmacokinetics, and Biotransformation in Preclinical and Clinical Studies: An Industry Perspective.
Kellie JF; Tran JC; Jian W; Jones B; Mehl JT; Ge Y; Henion J; Bateman KP
J Am Soc Mass Spectrom; 2021 Aug; 32(8):1886-1900. PubMed ID: 32869982
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry-based methods to characterize highly heterogeneous biopharmaceuticals, vaccines, and nonbiological complex drugs at the intact-mass level.
Kaltashov IA; Ivanov DG; Yang Y
Mass Spectrom Rev; 2024; 43(1):139-165. PubMed ID: 36582075
[TBL] [Abstract][Full Text] [Related]
16. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Characterization of Lysine-Linked Antibody Drug Conjugates Enabled by Middle-Down Mass Spectrometry and Higher-Energy Collisional Dissociation-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation and Ultraviolet Photodissociation.
Watts E; Bashyal A; Dunham SD; Crittenden CM; Brodbelt JS
Antibodies (Basel); 2024 Apr; 13(2):. PubMed ID: 38651410
[TBL] [Abstract][Full Text] [Related]
18. Rapid and Simultaneous Characterization of Drug Conjugation in Heavy and Light Chains of a Monoclonal Antibody Revealed by High-Resolution Ion Mobility Separations in SLIM.
Nagy G; Attah IK; Conant CR; Liu W; Garimella SVB; Gunawardena HP; Shaw JB; Smith RD; Ibrahim YM
Anal Chem; 2020 Apr; 92(7):5004-5012. PubMed ID: 32142606
[TBL] [Abstract][Full Text] [Related]
19. Quantitative mass spectrometry methods for pharmaceutical analysis.
Loos G; Van Schepdael A; Cabooter D
Philos Trans A Math Phys Eng Sci; 2016 Oct; 374(2079):. PubMed ID: 27644982
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
